Diagnostic and Prognostic Biomarkers of Idiopathic Intracranial Hypertension

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDanish Headache Center

About this trial

Idiopathic intracranial hypertension (IIH) is a condition of unknown etiology, primarily affecting overweight females of childbearing age. Typically, patients experience headache and visual symptoms due to increased intracranial pressure (ICP) and papilledema. The diagnosis is difficult, and outcomes vary from no sequelae to blindness or chronic headaches. No clear prognostic indicators exist. Treatment consists of medication, weight loss, and possibly surgical intervention.There is an unmet need of defining biomarkers with prognostic or diagnostic value and defining predictors of a poor outcome.

This project is a prospective, population-based cohort study including clinical data and a biobank (blood samples and cerebrospinal fluid).

The investigator's primary aim is to identify biomarkers of diagnostic or prognostic value and to create a clinical IIH database. The clinical database will answer questions about patient characteristics at baseline and during follow-up, identify predictors of outcome, and help create a standardized programme for follow-up and

Eligibility criteria

Qualifiers

Able to and willing to provide informed consent

More than 18 years of age

Suspicion of IIH (based on clinical evaluation by neurologist or opthalmologist)

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Standard treatment

Treatment groups

300 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Danish Headache Center

Lead sponsor

Odense University Hospital

Collaborator